title: Questioning the myth: benefits of renin-angiotensin system blockade in kidney transplant recipients.
authors.affiliation: 1 Centre for Transplant and Renal Research, Westmead Hospital, Westmead, New South Wales, Australia. 2 School of Public Health, University of Sydney, Sydney, Australia. 3 Centre for Kidney Research, Westmead Hospital, Westmead, New South Wales, Australia. 4 Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia. 5 Address correspondence to: Germaine Wong, Ph.D., Centre for Transplant and Renal research, Westmead Hospital, Westmead, New South Wales, Australia.
authors.forename: Germaine
authors.initials: G
authors.lastname: Wong
authors.forename: Wai H
authors.initials: WH
authors.lastname: Lim
authors.forename: Jeremy R
authors.initials: JR
authors.lastname: Chapman
mesh_terms: D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000378:metabolism* / Q000401:mortality*; D005260:Female; D006801:Humans; D016030:Kidney Transplantation / Q000379:methods*; D008297:Male; D012084:Renin-Angiotensin System / Q000187:drug effects*
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors